Ghrelin – The Hormone That Causes Hunger and Influences Satiety

Ghrelin, an orexigenic peptide hormone, predominantly synthesized by the enteroendocrine cells P/D1 of the gastric fundic mucosa, plays a central role in energy homeostasis by stimulating food intake and regulating metabolism. It acts by activating the growth hormone secretagogue receptor (GHS-R1a), located in the hypothalamus, thereby modulating the neuroendocrine signals involved in hunger perception and feeding behavior. This article will address the physiological mechanisms of ghrelin, its interactions with other neuropeptide hormones involved in appetite regulation—such as leptin, insulin, and neuropeptide Y—and current therapeutic strategies for optimizing the levels of this hormone in the context of weight management and metabolic disorders.

What is Ghrelin and What is its Role in Metabolic Homeostasis?

Photo Source: Shutterstock.com

Ghrelin is an orexigenic peptide hormone, predominantly secreted by the enteroendocrine P/D1 cells in the fundic mucosa of the stomach, as well as in smaller amounts by the small intestine, pancreas, and hypothalamus. It plays an essential role in regulating food intake and energy homeostasis, acting on the growth hormone secretagogue receptor (GHS-R1a) located in the hypothalamus. Ghrelin plasma levels increase under conditions of energy depletion, stimulating the lateral hypothalamus to initiate feeding behavior, and after food ingestion, they decrease, promoting satiety.

Besides its effects on appetite, ghrelin exhibits multiple physiological functions, including the modulation of carbohydrate metabolism through interaction with insulin and influencing insulin sensitivity in peripheral tissues. Furthermore, the hormone stimulates the secretion of growth hormone (GH) from the anterior pituitary, contributing to anabolic processes and the maintenance of muscle mass. At the cardiovascular level, ghrelin exerts cardioprotective effects by reducing oxidative stress and improving endothelial function.

Lastly, imbalances in ghrelin secretion and regulation are involved in the etiopathogenesis of obesity, anorexia, and other metabolic dysfunctions, highlighting the importance of this hormone in maintaining energy balance and metabolic health.

[cta_produs style=”style_1″ product=”91518″ image=”https://aronia-charlottenburg.com/wp-content/uploads/2025/03/Ce-este-grelina-si-care-este-rolul-sau-in-homeostazia-metabolica_-Omega-3.png”]

In this context, a balanced diet, supported by supplements that contribute to balancing metabolic processes, can effectively address these disorders. For example, Omega 3 supplements, such as our Omega 3 capsules with concentrated fish oil, represent an essential source of essential fatty acids that support cardiovascular and brain health. These capsules, with a concentration of 1000 mg of concentrated fish oil per capsule, provide an optimal dose of EPA (455 mg) and DHA (230 mg), essential in the biological modulators of inflammatory processes and in the regulation of lipid metabolism. Including them in the daily regimen can support neuroendocrine activity, contributing to better weight management and cognitive functions, thus facilitating the improvement of overall health status.

Ghrelin’s Mechanism of Action

Ghrelin exerts pleiotropic effects by activating the specific receptor GHS-R1a (Growth Hormone Secretagogue Receptor 1a), a G protein-coupled receptor predominantly expressed in the hypothalamus, pituitary, pancreas, and gastrointestinal tract. This orexigenic hormone regulates energy balance and appetite by stimulating orexigenic neurons in the arcuate nucleus of the hypothalamus, promoting the release of neuropeptide Y (NPY) and agouti-related protein (AgRP), two peptides involved in stimulating food intake and inhibiting anorexigenic signals.

Beyond its central role in energy homeostasis, ghrelin modulates the mesolimbic networks involved in the reward system, activating dopaminergic circuits in the ventral tegmental area and the cerebral amygdala, which influences food preferences and hedonic-motivational behaviors. At the peripheral level, ghrelin interferes with glucose homeostasis, inhibiting insulin secretion from pancreatic β-cells and reducing peripheral glucose uptake through actions on the liver and skeletal muscle.

Ghrelin’s pulsatile secretion follows a circadian rhythm and is influenced by nutritional status, reaching peak values during preprandial periods and diminishing postprandially, in correlation with the release of insulin and anorexigenic peptides such as peptide YY (PYY) and cholecystokinin (CCK).

Through this dynamic, ghrelin acts as an essential metabolic sensor in adapting the body to variations in energy availability and in regulating body weight.

The Relationship Between Ghrelin and Leptin

Photo Source: Shutterstock.com

Ghrelin and leptin are two essential hormones in energy homeostasis, acting through complementary mechanisms to regulate feeding behavior and metabolism.

*Ghrelin*, predominantly secreted by the enteroendocrine cells of the gastric fundus, is an orexigenic hormone that stimulates food intake by activating orexigenic NPY/AgRP neurons in the arcuate nucleus of the hypothalamus. In contrast, *leptin*, synthesized by adipocytes according to adipose tissue mass, has an anorexigenic effect, inhibiting these same neurons and activating the anorexigenic pathway represented by POMC/CART neurons.

The interaction between ghrelin and leptin is bidirectional and finely regulated: leptin modulates the expression of the GHS-R1a receptor at the hypothalamic level and suppresses ghrelin secretion at the gastric level, contributing to reduced food intake. In metabolic syndrome and obesity, this balance is altered, characterized by hyperleptinemia and leptin resistance, which hinders the inhibitory effect on ghrelin and perpetuates the sensation of hunger, favoring excessive caloric intake.

Optimal regulation of the ghrelin/leptin ratio is influenced by factors such as circadian rhythm, diet composition, physical activity, and systemic inflammatory status. For example, sleep deprivation leads to increased ghrelin levels and decreased leptin secretion, promoting hyperphagia. Supplementation with Omega-3 polyunsaturated fatty acids has been shown to have beneficial effects in sensitizing to leptin and reducing ghrelin levels, contributing to optimizing energy balance and preventing obesity.

Although ghrelin and leptin are central factors in appetite regulation, this process also involves other neuroendocrine mediators, such as insulin, peptide YY (PYY), and cholecystokinin (CCK), each having a specific role in the dynamics of food intake. An integrated understanding of these mechanisms can facilitate the development of effective therapeutic strategies for managing obesity and associated metabolic disorders.

Impact of Ghrelin on Energy Homeostasis and Body Weight

Ghrelin is a central regulator of energy balance that influences appetite, the metabolism of energy substrates, and adipose tissue storage. Its pulsatile secretion is closely linked to nutritional status, reaching peak levels during periods of fasting and decreasing postprandially. By activating GHS-R1a receptors at the hypothalamic level, ghrelin stimulates food intake by increasing the expression of neuropeptide Y (NPY) and AgRP, with a pronounced orexigenic effect.

Beyond increasing caloric intake, ghrelin modulates lipid metabolism by promoting lipogenesis and reducing the rate of fatty acid oxidation, favoring the accumulation of adipose tissue, particularly in the visceral region. Ghrelin also interferes with carbohydrate metabolism, exerting an antagonistic effect on insulin by inhibiting its secretion and reducing insulin sensitivity in peripheral tissues.

In the context of obesity, the ghrelin profile presents paradoxical characteristics. Although circulating ghrelin levels are often reduced in obese patients, sensitivity to its orexigenic effects may be amplified. This contributes to the difficulty in controlling food intake. Furthermore, during caloric restriction, plasma ghrelin concentrations increase compensatorily. This can lead to reactive hyperphagia and compromise the long-term maintenance of weight loss.

Managing ghrelin’s impact on energy homeostasis requires multimodal interventions. These include optimizing diet with adequate protein and fiber intake. These can reduce postprandial ghrelin secretion. Regular physical activity is also important for improving sensitivity to leptin and insulin. Optimizing sleep is also essential, given the impact of sleep deprivation on increased ghrelin secretion. Additionally, pharmacological strategies and metabolic interventions, such as bariatric surgery, significantly influence ghrelin secretion and action. These are essential aspects in the treatment of severe obesity.

Therefore, ghrelin does not act in isolation but in interdependence with other metabolic hormones and neuroendocrine factors. This necessitates a holistic and personalized approach in managing weight and associated metabolic disorders.

Strategies for Modulating Ghrelin Secretion and Activity

Photo Source: Shutterstock.com

Regulating ghrelin levels is essential for optimizing energy homeostasis, controlling appetite, and preventing metabolic disorders. Nutritional, behavioral, and pharmacological interventions can influence the secretion and action of this peptide hormone, contributing to maintaining metabolic balance.

Here are some recommendations for regulating ghrelin levels, essential for maintaining appetite and energy metabolism balance:

1. Nutritional Interventions

Dietary structure plays a decisive role in the dynamics of ghrelin secretion. Increased protein intake induces a significant and sustained reduction in plasma ghrelin concentration by delaying gastric emptying and stimulating anorexigenic hormones such as peptide YY (PYY) and cholecystokinin (CCK). Also, consuming foods rich in soluble fiber contributes to prolonging the feeling of satiety through colonic fermentation and the production of short-chain fatty acids, which modulate the gut-brain axis.

Conversely, high glycemic index foods cause a transient increase in postprandial ghrelin, favoring hyperphagia and weight gain. Therefore, a balanced diet, based on foods with slow glucose release, can prevent marked ghrelin fluctuations and stabilize appetite.

2. Circadian Rhythm and Sleep Impact

Sleep deprivation induces a disruption of the hypothalamic-pituitary-adrenal axis and leads to increased ghrelin secretion, amplifying the perception of hunger and susceptibility to overeating. A series of clinical studies have shown that quality sleep, lasting at least 7-9 hours per night, optimizes the ghrelin-leptin ratio and reduces the risk of weight gain.

3. Physical Activity and Its Effects on Ghrelin

Physical exercise influences ghrelin secretion in a manner dependent on intensity and duration. Moderate physical activity causes a transient decrease in ghrelin levels, correlated with increased leptin and PYY secretion. In contrast, high-intensity training can have variable effects, sometimes increasing ghrelin levels during prolonged exertion, due to the need to restore energy reserves.

4. Stress Control and Neuroendocrine Regulation Techniques

Chronic stress can amplify ghrelin secretion, playing an important role in compulsive eating behaviors and stress-induced weight gain. Psychological interventions, such as mindfulness, meditation, or biofeedback, have demonstrated the ability to modulate ghrelin secretion and improve the self-regulation of food intake.

5. Pharmacological and Metabolic Interventions

In cases of severe obesity, bariatric interventions, such as sleeve gastrectomy, significantly reduce ghrelin secretion. This is achieved by removing the gastric fundus, its main production site. Furthermore, pharmacological agents targeting GHS-R1a receptors or modulating ghrelin’s interaction with orexigenic systems are under research. These are being studied for the treatment of obesity and associated metabolic disorders.

In other words, regulating ghrelin secretion and activity requires a multidisciplinary approach. This integrates nutritional strategies, lifestyle modifications, and, in specific cases, pharmacological or surgical interventions. Only a detailed understanding of the neuroendocrine mechanisms involved in appetite control is essential. This is necessary for developing effective therapies in preventing and managing obesity.

Ghrelin and Metabolic Disorders – An Endocrinological Perspective

A peptide hormone predominantly secreted by the enteroendocrine cells of the gastric fundic mucosa, ghrelin is a key regulator of energy homeostasis and carbohydrate metabolism. It has significant implications in the pathophysiology of obesity, diabetes mellitus, and other metabolic diseases. By activating its specific receptor, GHS-R1a (ghrelin receptor type 1a), ghrelin exerts orexigenic effects. These are achieved by stimulating AgRP/NPY neurons in the hypothalamus. This leads to an increase in food intake and a reduction in energy expenditure.

In obesity, circulating ghrelin levels are paradoxically lower compared to normal-weight individuals. However, increased peripheral sensitivity to this hormone and impaired hypothalamic axis regulation can contribute to hyperphagia. They can also alter energy homeostasis mechanisms. Ghrelin plays a major role in glucose homeostasis. It inhibits insulin secretion from the pancreas and reduces tissue sensitivity to insulin. These mechanisms favor the onset and progression of type 2 diabetes mellitus.

Ghrelin – Implications in Prader-Willi Syndrome

A particular case of ghrelinergic system deregulation is Prader-Willi Syndrome. This is a genetic disorder characterized by severe hyperphagia, muscle hypotonia, and psychomotor retardation. In patients with this syndrome, ghrelin levels are significantly elevated. This contributes to the development of morbid obesity. Unlike other forms of obesity, where ghrelin levels decrease postprandially, patients with this syndrome exhibit persistently high ghrelin secretion. This suggests a defect in the inhibitory feedback of this hormone on the hypothalamic appetite centers.

Besides its impact on energy metabolism, ghrelin exhibits pleiotropic effects. It is involved in cardiovascular protection by reducing oxidative stress. It also improves endothelial function and inhibits systemic inflammation. Recent studies suggest that ghrelin also modulates the hypothalamic-pituitary-adrenal axis. It has anxiolytic and antidepressant effects by influencing dopaminergic and serotonergic neurotransmission. This observation opens new therapeutic perspectives. Ghrelinergic modulators could be used in the management of mood disorders.

Ghrelin – Therapeutic Perspectives

From a therapeutic standpoint, blocking ghrelinergic signaling through antagonists of GHS-R1a represents an emerging strategy. This is useful for the treatment of obesity and type 2 diabetes mellitus. On the other hand, ghrelin agonists are being investigated for use in cachexia associated with chronic diseases, anorexia nervosa, and malabsorption syndromes. Furthermore, compounds capable of modulating ghrelin secretion dynamics could represent innovative therapeutic solutions. These could optimize energy metabolism and prevent severe metabolic diseases.

In conclusion, ghrelin is a central element in the pathophysiology of metabolic and neuroendocrine diseases. Elucidating its mechanisms of action and its interactions with leptin and other appetite hormones offers valuable insights. These can contribute to the development of targeted therapies. Such therapies could modulate energy balance and prevent associated metabolic complications.

References:

1. Müller, T. D., Nogueiras, R., Andermann, M. L., Andrews, Z. B., Anker, S. D., Argente, J., … & Tschöp, M. H. (2015). Ghrelin. Molecular metabolism, 4(6), 437-460. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4443295/;
2. Nakazato, M., Murakami, N., Date, Y., Kojima, M., Matsuo, H., Kangawa, K., & Matsukura, S. (2001). A role for ghrelin in the central regulation of feeding. Nature, 409(6817), 194-198. https://www.nature.com/articles/35051587;
3. Cummings, D. E., & Overduin, J. (2007). Gastrointestinal regulation of food intake. The Journal of clinical investigation, 117(1), 13-23. https://www.jci.org/articles/view/30227;
4. Klok, M. D., Jakobsdottir, S., & Drent, M. L. (2007). The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review. Obesity reviews, 8(1), 21-34. https://onlinelibrary.wiley.com/doi/full/10.1111/j.1467-789X.2006.00270.x;
5. De Silva A, Bloom SR. Gut Hormones and Appetite Control: A Focus on PYY and GLP-1 as Therapeutic Targets in Obesity. Gut Liver. 2012 Jan;6(1):10-20. doi: 10.5009/gnl.2012.6.1.10. Epub 2012 Jan 12. PMID: 22375166; PMCID: PMC3286726.

Photo Source: Shutterstock.com